These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 16207994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapy.
    Ibáñez A, Clotet B, Martínez MA.
    Virology; 2001 Mar 30; 282(1):1-5. PubMed ID: 11259184
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.
    Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Palmisano L, Andreotti M, Andreoni C, Giuliano M, Gatti F, Boldrin C, Palù G, Vullo V, Vella S, Andreoni M.
    J Clin Microbiol; 2005 Dec 30; 43(12):6183-5. PubMed ID: 16333125
    [Abstract] [Full Text] [Related]

  • 5. Measuring covert HIV replication during HAART: the abundance of 2-LTR circles is not a reliable marker.
    Bushman F.
    AIDS; 2003 Mar 28; 17(5):749-50. PubMed ID: 12646799
    [No Abstract] [Full Text] [Related]

  • 6. Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA.
    Cara A, Vargas J, Keller M, Jones S, Mosoian A, Gurtman A, Cohen A, Parkas V, Wallach F, Chusid E, Gelman IH, Klotman ME.
    Virology; 2002 Jan 05; 292(1):1-5. PubMed ID: 11878902
    [Abstract] [Full Text] [Related]

  • 7. Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA.
    Cara A, Maggiorella MT, Bona R, Sernicola L, Baroncelli S, Negri DR, Leone P, Fagrouch Z, Heeney J, Titti F, Cafaro A, Ensoli B.
    Virology; 2004 Jul 01; 324(2):531-9. PubMed ID: 15207638
    [Abstract] [Full Text] [Related]

  • 8. Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.
    Delaugerre C, Charreau I, Braun J, Néré ML, de Castro N, Yeni P, Ghosn J, Aboulker JP, Molina JM, Simon F, ANRS 138 study group.
    AIDS; 2010 Sep 24; 24(15):2391-5. PubMed ID: 20683319
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species.
    Brussel A, Sonigo P.
    J Virol; 2004 Oct 24; 78(20):11263-71. PubMed ID: 15452245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 24; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 13. Failure to eradicate HIV despite fully successful HAART initiated in the first days of life.
    Viganò A, Trabattoni D, Schneider L, Ottaviani F, Aliffi A, Longhi E, Rusconi S, Clerici M.
    J Pediatr; 2006 Mar 24; 148(3):389-91. PubMed ID: 16615974
    [Abstract] [Full Text] [Related]

  • 14. Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo.
    Fischer M, Trkola A, Joos B, Hafner R, Joller H, Muesing MA, Kaufman DR, Berli E, Hirschel B, Weber R, Günthard HF, Swiss HIV-1 Cohort Study.
    Antivir Ther; 2003 Apr 24; 8(2):97-104. PubMed ID: 12741621
    [Abstract] [Full Text] [Related]

  • 15. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
    Mohey R, Jørgensen LB, Møller BK, Black FT, Kjems J, Obel N.
    J Clin Virol; 2005 Dec 24; 34(4):257-67. PubMed ID: 16286049
    [Abstract] [Full Text] [Related]

  • 16. Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells.
    Reigadas S, Andréola ML, Wittkop L, Cosnefroy O, Anies G, Recordon-Pinson P, Thiébaut R, Masquelier B, Fleury H.
    J Antimicrob Chemother; 2010 Mar 24; 65(3):434-7. PubMed ID: 20051476
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.
    Brussel A, Mathez D, Broche-Pierre S, Lancar R, Calvez T, Sonigo P, Leibowitch J.
    AIDS; 2003 Mar 28; 17(5):645-52. PubMed ID: 12646786
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
    Jurriaans S, de Ronde A, Dekker J, Cornelissen M, Goudsmit J.
    J Med Virol; 1995 Jan 28; 45(1):91-8. PubMed ID: 7714497
    [Abstract] [Full Text] [Related]

  • 20. Sustained viremia during highly active antiretroviral therapy with accelerated proviral DNA decay in the setting of infection with syphilis.
    Padte N, Rowe L, Hurley A, Simon V, Markowitz M.
    AIDS; 2003 Sep 26; 17(14):2143-5. PubMed ID: 14502027
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.